Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Schembl20971391
2. Ganglioside Gm1 Sphinganine (bovine)
3. Monosialoganglioside Gm1 From Bovine Brain
4. Ganglioside Gm, Ammonium Salt, Bovine Brain
5. Ganglioside Gm, Ammonium Salt, Bovine Brain - Cas 37758-47-7
6. Galactosyl-n-acetylgalactosaminyl-(n-acetylneuraminyl)-galactosyl-glucosylceramide
| Molecular Weight | 1602.9 g/mol |
|---|---|
| Molecular Formula | C77H139N3O31 |
| XLogP3 | 6.2 |
| Hydrogen Bond Donor Count | 20 |
| Hydrogen Bond Acceptor Count | 31 |
| Rotatable Bond Count | 56 |
| Exact Mass | 1601.9392546 g/mol |
| Monoisotopic Mass | 1601.9392546 g/mol |
| Topological Polar Surface Area | 541 Ų |
| Heavy Atom Count | 111 |
| Formal Charge | 0 |
| Complexity | 2580 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 28 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Sodium Monosialotetrahexosylganglioside manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Monosialotetrahexosylganglioside, including repackagers and relabelers. The FDA regulates Sodium Monosialotetrahexosylganglioside manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Monosialotetrahexosylganglioside API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium Monosialotetrahexosylganglioside manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium Monosialotetrahexosylganglioside supplier is an individual or a company that provides Sodium Monosialotetrahexosylganglioside active pharmaceutical ingredient (API) or Sodium Monosialotetrahexosylganglioside finished formulations upon request. The Sodium Monosialotetrahexosylganglioside suppliers may include Sodium Monosialotetrahexosylganglioside API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium Monosialotetrahexosylganglioside suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Sodium Monosialotetrahexosylganglioside Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Monosialotetrahexosylganglioside GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Monosialotetrahexosylganglioside GMP manufacturer or Sodium Monosialotetrahexosylganglioside GMP API supplier for your needs.
A Sodium Monosialotetrahexosylganglioside CoA (Certificate of Analysis) is a formal document that attests to Sodium Monosialotetrahexosylganglioside's compliance with Sodium Monosialotetrahexosylganglioside specifications and serves as a tool for batch-level quality control.
Sodium Monosialotetrahexosylganglioside CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Monosialotetrahexosylganglioside CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Monosialotetrahexosylganglioside may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Monosialotetrahexosylganglioside EP), Sodium Monosialotetrahexosylganglioside JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Monosialotetrahexosylganglioside USP).
LOOKING FOR A SUPPLIER?
